Literature DB >> 27809394

Precision wildlife medicine: applications of the human-centred precision medicine revolution to species conservation.

Jenny Whilde1, Mark Q Martindale1, David J Duffy1,2.   

Abstract

The current species extinction crisis is being exacerbated by an increased rate of emergence of epizootic disease. Human-induced factors including habitat degradation, loss of biodiversity and wildlife population reductions resulting in reduced genetic variation are accelerating disease emergence. Novel, efficient and effective approaches are required to combat these epizootic events. Here, we present the case for the application of human precision medicine approaches to wildlife medicine in order to enhance species conservation efforts. We consider how the precision medicine revolution, coupled with the advances made in genomics, may provide a powerful and feasible approach to identifying and treating wildlife diseases in a targeted, effective and streamlined manner. A number of case studies of threatened species are presented which demonstrate the applicability of precision medicine to wildlife conservation, including sea turtles, amphibians and Tasmanian devils. These examples show how species conservation could be improved by using precision medicine techniques to determine novel treatments and management strategies for the specific medical conditions hampering efforts to restore population levels. Additionally, a precision medicine approach to wildlife health has in turn the potential to provide deeper insights into human health and the possibility of stemming and alleviating the impacts of zoonotic diseases. The integration of the currently emerging Precision Medicine Initiative with the concepts of EcoHealth (aiming for sustainable health of people, animals and ecosystems through transdisciplinary action research) and One Health (recognizing the intimate connection of humans, animal and ecosystem health and addressing a wide range of risks at the animal-human-ecosystem interface through a coordinated, collaborative, interdisciplinary approach) has great potential to deliver a deeper and broader interdisciplinary-based understanding of both wildlife and human diseases.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  EcoHealth; One Health; chytridiomycosis; emerging disease; environmental DNA (eDNA); epizootic disease; fibropapillomatosis; systems medicine; wildlife cancer; wildlife disease

Mesh:

Year:  2016        PMID: 27809394     DOI: 10.1111/gcb.13548

Source DB:  PubMed          Journal:  Glob Chang Biol        ISSN: 1354-1013            Impact factor:   10.863


  8 in total

1.  Hematology and serum biochemistry of free-range brown-throated sloths in two urban areas in Brazil.

Authors:  Kissia Ferreira Pereira; Ita de Oliveira E Silva; Fernanda de Fátima Rodrigues Silva; Vinicius Herold Dornelas E Silva; Carla Soraia Soares de Castro; Vanner Boere
Journal:  Vet World       Date:  2020-09-30

2.  Environmental DNA monitoring of oncogenic viral shedding and genomic profiling of sea turtle fibropapillomatosis reveals unusual viral dynamics.

Authors:  Jessica A Farrell; Kelsey Yetsko; Liam Whitmore; Jenny Whilde; Catherine B Eastman; Devon Rollinson Ramia; Rachel Thomas; Paul Linser; Simon Creer; Brooke Burkhalter; Christine Schnitzler; David J Duffy
Journal:  Commun Biol       Date:  2021-05-12

3.  Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.

Authors:  David J Duffy; Aleksandar Krstic; Melinda Halasz; Thomas Schwarzl; Anja Konietzny; Kristiina Iljin; Desmond G Higgins; Walter Kolch
Journal:  Genome Med       Date:  2017-02-10       Impact factor: 11.117

4.  Perspectives on the expansion of human precision oncology and genomic approaches to sea turtle fibropapillomatosis.

Authors:  David J Duffy; Mark Q Martindale
Journal:  Commun Biol       Date:  2019-02-07

5.  Molecular characterization of a marine turtle tumor epizootic, profiling external, internal and postsurgical regrowth tumors.

Authors:  Kelsey Yetsko; Jessica A Farrell; Nicholas B Blackburn; Liam Whitmore; Maximilian R Stammnitz; Jenny Whilde; Catherine B Eastman; Devon Rollinson Ramia; Rachel Thomas; Aleksandar Krstic; Paul Linser; Simon Creer; Gary Carvalho; Mariana A Devlin; Nina Nahvi; Ana Cristina Leandro; Thomas W deMaar; Brooke Burkhalter; Elizabeth P Murchison; Christine Schnitzler; David J Duffy
Journal:  Commun Biol       Date:  2021-02-01

6.  Transcriptomic Profiling of Fibropapillomatosis in Green Sea Turtles (Chelonia mydas) From South Texas.

Authors:  Nicholas B Blackburn; Ana Cristina Leandro; Nina Nahvi; Mariana A Devlin; Marcelo Leandro; Ignacio Martinez Escobedo; Juan M Peralta; Jeff George; Brian A Stacy; Thomas W deMaar; John Blangero; Megan Keniry; Joanne E Curran
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

7.  Nutritional Metabolites as Biomarkers of Previous Feed Intake in European Rabbit (Oryctolagus cuniculus): Applications on Conservation.

Authors:  Pablo Jesús Marín-García; Lola Llobat; Carlos Rouco; Juan Antonio Aguayo-Adán; Torben Larsen; María Cambra-López; Enrique Blas; Juan José Pascual
Journal:  Animals (Basel)       Date:  2022-09-28       Impact factor: 3.231

8.  Sea turtle fibropapilloma tumors share genomic drivers and therapeutic vulnerabilities with human cancers.

Authors:  David J Duffy; Christine Schnitzler; Lorraine Karpinski; Rachel Thomas; Jenny Whilde; Catherine Eastman; Calvin Yang; Aleksandar Krstic; Devon Rollinson; Bette Zirkelbach; Kelsey Yetsko; Brooke Burkhalter; Mark Q Martindale
Journal:  Commun Biol       Date:  2018-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.